Searched for
ACTIVE PHARMACEUTICAL INGREDIENT
Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDAFollowing an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Vol...- Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
- For long- and medium-term investors: Cycles turn, principles don’t; 5 large-cap stocks with upside potential of up to 29%These are the stocks that fell the most, so they may bounce back the most if the fund flows return. They are the ones FPI money will target...
- Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
- These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
- HRV Pharma buys Germany's PhateboThe acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Time to be be cautious in the market, convinced about the business: 5 large-cap stocks with upside potential of up to 22%This is the time to focus on businesses that have lived through storms like this before and come out the other side. The large, proven name...
- Pharma company Gufic buys luxury duplex in Mumbai’s Juhu for over Rs 236 crGufic has made a significant real estate purchase with the acquisition of a luxury apartment in Mumbai. The duplex is located in the upscal...
- 'Forever chemicals' can remain in water for years, but can a new UV technology finally destroy them? Here's how it worksThe process targets the carbon-fluorine bonds in PFAS compounds, which are responsible for their exceptional chemical stability. The compan...
- These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsHere’s one thing that is worth clarifying, because it is in the headlines. Large global technology companies have been announcing heavy spe...
- PM Modi reviews projects worth over Rs 16,000 crore across 31 States, UTs at 54th PRAGATI meetingPrime Minister Narendra Modi chaired the 54th PRAGATI meeting to evaluate infrastructure projects worth over Rs 16,000 crore. The meeting f...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhen a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...
- Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini PiramalIn a strategic move to enhance risk management, Piramal Pharma has drastically cut its reliance on Chinese raw materials to under 10%. The ...
- Cipla’s US recovery, biosimilar pipeline key to future growth prospectsCipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its str...
- India considers measures to boost local production of 100 critical inputs to cut import reliance, government official saysIndia is taking steps to encourage the local manufacturing of 100 key items that are currently imported. This initiative aims to decrease d...
- Forget short-term pressure; in the long term, the right business is what pays: 5 mid-cap stocks with an upside potential of up to 36%We have said this before, and we say it again: No one can predict when the market will bottom out. You can see the bottom only in hindsight...
- Dr Reddy’s Q2 Results: Net profit falls 36% YoY to Rs 913 crore, revenue declines marginallyDr Reddy’s Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27, while revenue slipped 1.5%. North America ...
- Europe’s last penicillin plant faces a bitter fight against China’s cheaper drugsThe Sandoz penicillin plant in Kundl, Austria, is under threat from cheaper Chinese antibiotic production. European healthcare programs ben...
Load More
